Bottom Line: PhRMA fights patent waiver expansion for COVID treatments ...Middle East

News by : (The Hill) -
Pharmaceuticals ​Pharmaceutical Research and Manufacturers of America (PhRMA) hired Altrius Group to lobby on a proposal to expand the World Trade Organization waiver on certain intellectual property protections for COVID-19 vaccines to include additional COVID-19 treatments. The pharmaceutical industry trade group called the proposed waiver expansion “harmful and unnecessary,” saying it could threaten innovation, jobs and pandemic preparedness by discouraging investment in the development of new technologies. William Morley, founder of Altrius Group and former general counsel to former Sen. Arlen Specter (D-Pa.), will work on the account. Novo Nordisk hired Subject Matter to lobb

Hence then, the article about bottom line phrma fights patent waiver expansion for covid treatments was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bottom Line: PhRMA fights patent waiver expansion for COVID treatments )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار